Why the Coming Debate Over the QALY and Disability Will be Different

G. Persad , “Considering Quality of Life while Repudiating Disability Injustice: A Pathways Approach to Setting Priorities,” Journal of Law, Medicine & Ethics 47, no. 2 (2019): 294-303.

P. J. Neumann and D. Greenberg , “Is the United States Ready For QALYs?” Health Affairs 28, no. 5 (2009): 1366–1371.

Id.

G. D. Sanders , P. J. Neumann , and A. Basu , et al., “Recommendations for Conduct, Methodological Practices, and Reporting of Cost-Effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine,” JAMA 316, no. 10 (2016): 1093-1103; L. P. Garrison, P. J. Neumann, and R. J. Willke et al., “A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7]” Value Health 21, no. 2 (2018): 161-165.

V.T. Reckers-Droog , N. J. A. van Exel , and W. B. F Brouwer , “Looking Back and Moving Forward: On the Application of Proportional Shortfall in Healthcare Priority Setting in the Netherlands,” Health Policy 122, no. 6 (2018): 621-629; National Institute for Health and Care Excellence (NICE), “Appraising Life-Extending, End of Life Treatments,” July 2009, available at <https://www.nice.org.uk/guidance/gidtag387/documents/appraising-life-extending-end-of-life-treatments-paper2> (last visited April 5, 2019).

A. Gopalan , “CVS Announcement of Cost-Effective Benchmarks Puts ICER in the Spotlight,” STAT, August 22, 2018, available at <https://www.statnews.com/2018/08/22/cvs-cost-effectiveness-benchmarks-puts-icer/> (last visited April 5, 2019).

A. Dunn , “Patient Groups Attack CVS use of ICER Metrics, Urge Rethink,” BioPharmaDive, September 14, 2018, available at <https://www.biopharmadive.com/news/patient-groups-attack-cvs-use-of-icer-metrics-urge-rethink/532383/> (last visited April 5, 2019).

Institute for Clinical and Economic Review (ICER), “The QALY: Rewarding the Care That Most Improves Patients' Lives,” December 2018, available at <https://icer-review.org/wp-content/uploads/2018/12/QALY_evLYG_FINAL.pdf> (last visited April 5, 2019).

E. McCallister , “Arbiter of Value: How ICER is Becoming the U.S.'s de factor HTA Agency,” March 23, 2018, available at <https://www.biocentury.com/biocentury/strategy/2018-03-23/how-icer-becoming-us%E2%80%99s-de-facto-hta-agency> (last visited April 5, 2019).

M. M. Singleton , “Eugenics, Euthanasia, Infanticide, and the Lord's Work,” February 4, 2019, available at <https://aapsonline.org/eugenics-euthanasia-infanticide-and-the-lords-work/> (last visited April 5, 2019).